Blog
About

11
views
0
recommends
+1 Recommend
1 collections
    4
    shares
      • Record: found
      • Abstract: found
      • Article: found

      Transformation in follicular lymphoma: biology, prognosis, and therapeutic options.

      Current Oncology Reports

      physiology, Tumor Microenvironment, metabolism, Tumor Markers, Biological, Transplantation, Autologous, methods, Stem Cell Transplantation, Risk Factors, Prognosis, Positron-Emission Tomography, therapy, pathology, Lymphoma, Large B-Cell, Diffuse, diagnosis, Lymphoma, Follicular, Humans, genetics, Cell Transformation, Neoplastic, therapeutic use, Antineoplastic Combined Chemotherapy Protocols

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          The transformation of follicular lymphoma to an aggressive lymphoma is a well-recognised complication that occurs at a rate of approximately 3 % a year for the first 10 years of observation. Transformation is accompanied by increased risk of refractoriness and a poor expectation of survival. Genetic and epigenetic triggers for transformation have been described. Prior to routine use of rituximab, transformed lymphoma was managed in a fashion similar to that for de novo diffuse large B-cell lymphoma, with generally poor results. Rituximab appears to have improved outcomes. Some centres, including our own, use high-dose chemotherapy with stem cell transplantation as consolidation for those with responsive disease. Here, we focus on transformed follicular lymphoma, and provide an overview of the current literature and our approach to management.

          Related collections

          Author and article information

          Journal
          22865028
          10.1007/s11912-012-0258-4

          Comments

          Comment on this article